BRIEF-Celsion provides update on Thermodox in liver cancer study
September 27, 2017 at 09:03 AM EDT
* Celsion provides update on Thermodox® in the Phase III Optima study of primary liver cancer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.